Skip to main content
Top
Published in: Supportive Care in Cancer 12/2021

Open Access 01-12-2021 | Care | Original Article

Development of an integrated model of care for allogeneic stem cell transplantation facilitated by eHealth—the SMILe study

Authors: Lynn Leppla, Anja Schmid, Sabine Valenta, Juliane Mielke, Sonja Beckmann, Janette Ribaut, Alexandra Teynor, Fabienne Dobbels, Nathalie Duerinckx, Robert Zeiser, Monika Engelhardt, Sabine Gerull, Sabina De Geest, the SMILe study team

Published in: Supportive Care in Cancer | Issue 12/2021

Login to get access

Abstract

Purpose

Allogeneic stem cell transplantation would benefit from re-engineering care towards an integrated eHealth-facilitated care model. With this paper we aim to: (1) describe the development of an integrated care model (ICM) in allogeneic SteM-cell-transplantatIon faciLitated by eHealth (SMILe) by combining implementation, behavioral, and computer science methods (e.g., contextual analysis, Behavior Change Wheel, and user-centered design combined with agile software development); and (2) describe that model’s characteristics and its application in clinical practice.

Methods

The SMILe intervention’s development consisted of four steps, with implementation science methods informing each: (1) planning its set-up within a theoretical foundation; (2) using behavioral science methods to develop the content; (3) choosing and developing its delivery method (human/technology) using behavioral and computer science methods; and (4) describing its characteristics and application in clinical practice.

Results

The SMILe intervention is embedded within the eHealth enhanced Chronic Care Model, entailing four self-management intervention modules, targeting monitoring and follow-up of important medical and symptom-related parameters, infection prevention, medication adherence, and physical activity. Interventions are delivered partly face-to-face by a care coordinator embedded within the transplant team, and partly via the SMILeApp that connects patients to the transplant team, who can monitor and rapidly respond to any relevant changes within 1 year post-transplant.

Conclusion

This paper provides stepwise guidance on how implementation, behavioral, and computer science methods can be used to develop interventions aiming to improve care for stem cell transplant patients in real-world clinical settings. This new care model is currently being tested in a hybrid I effectiveness-implementation trial.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gifford G, Sim J, Horne A, Ma D (2014) Health status, late effects and long-term survivorship of allogeneic bone marrow transplantation: a retrospective study. Int Med J 44(2):139–147CrossRef Gifford G, Sim J, Horne A, Ma D (2014) Health status, late effects and long-term survivorship of allogeneic bone marrow transplantation: a retrospective study. Int Med J 44(2):139–147CrossRef
4.
go back to reference Ice LL, Bartoo GT, McCullough KB, Wolf RC, Dierkhising RA, Mara KC, Jowsey-Gregoire SG, Damlaj M, Litzow MR, Merten JA (2020) A prospective survey of outpatient medication adherence in adult allogeneic hematopoietic stem cell transplant patients. Biol Blood Marrow Transplant Ice LL, Bartoo GT, McCullough KB, Wolf RC, Dierkhising RA, Mara KC, Jowsey-Gregoire SG, Damlaj M, Litzow MR, Merten JA (2020) A prospective survey of outpatient medication adherence in adult allogeneic hematopoietic stem cell transplant patients. Biol Blood Marrow Transplant
5.
go back to reference Kirsch M, Götz A, Halter J, Schanz U, Stussi G, Dobbels F, De Geest S (2014) Differences in health behaviour between recipients of allogeneic haematopoietic SCT and the general population: a matched control study. Bone MarrowTransplant 49(9):1223–1230 Kirsch M, Götz A, Halter J, Schanz U, Stussi G, Dobbels F, De Geest S (2014) Differences in health behaviour between recipients of allogeneic haematopoietic SCT and the general population: a matched control study. Bone MarrowTransplant 49(9):1223–1230
6.
go back to reference Majhail NS (2017) Long-term complications after hematopoietic cell transplantation. Hematol Oncol Stem Cell Ther Majhail NS (2017) Long-term complications after hematopoietic cell transplantation. Hematol Oncol Stem Cell Ther
7.
go back to reference Goodwin N (2016) Understanding integrated care. Int J Integr Care 16 (4) Goodwin N (2016) Understanding integrated care. Int J Integr Care 16 (4)
8.
go back to reference Nuño R, Coleman K, Bengoa R, Sauto R (2012) Integrated care for chronic conditions: the contribution of the ICCC Framework. Health Policy 105(1):55–64CrossRef Nuño R, Coleman K, Bengoa R, Sauto R (2012) Integrated care for chronic conditions: the contribution of the ICCC Framework. Health Policy 105(1):55–64CrossRef
9.
go back to reference Wagner Q EH, Austin BT, Von Korff M (1996) Organizing care for patients with chronic illness. Milbank:511–544 Wagner Q EH, Austin BT, Von Korff M (1996) Organizing care for patients with chronic illness. Milbank:511–544
11.
go back to reference Gee PM, Greenwood DA, Paterniti DA, Ward D, Miller LMS (2015) The eHealth enhanced chronic care model: a theory derivation approach. J Med Internet Res 17 (4) Gee PM, Greenwood DA, Paterniti DA, Ward D, Miller LMS (2015) The eHealth enhanced chronic care model: a theory derivation approach. J Med Internet Res 17 (4)
13.
go back to reference Elbert NJ, van Os-Medendorp H, van Renselaar W, Ekeland AG, Hakkaart-van Roijen L, Raat H, Nijsten TE, Pasmans SG (2014) Effectiveness and cost-effectiveness of ehealth interventions in somatic diseases: a systematic review of systematic reviews and meta-analyses. J Med Int Res 16 (4) Elbert NJ, van Os-Medendorp H, van Renselaar W, Ekeland AG, Hakkaart-van Roijen L, Raat H, Nijsten TE, Pasmans SG (2014) Effectiveness and cost-effectiveness of ehealth interventions in somatic diseases: a systematic review of systematic reviews and meta-analyses. J Med Int Res 16 (4)
14.
go back to reference Widmer RJ, Collins NM, Collins CS, West CP, Lerman LO, Lerman A Digital health interventions for the prevention of cardiovascular disease: a systematic review and meta-analysis. In: Mayo Clin Proc, 2015. vol 4. Elsevier, pp 469–480 Widmer RJ, Collins NM, Collins CS, West CP, Lerman LO, Lerman A Digital health interventions for the prevention of cardiovascular disease: a systematic review and meta-analysis. In: Mayo Clin Proc, 2015. vol 4. Elsevier, pp 469–480
15.
go back to reference Michaud TL, Zhou J, McCarthy MA, Siahpush M, Su D (2018) Costs of home-based telemedicine programs: a systematic review. Int J Technol Assess Health Care 34(4):410–418CrossRef Michaud TL, Zhou J, McCarthy MA, Siahpush M, Su D (2018) Costs of home-based telemedicine programs: a systematic review. Int J Technol Assess Health Care 34(4):410–418CrossRef
17.
go back to reference Kaier K, Hils S, Fetzer S, Hehn P, Schmid A, Hauschke D, Bogatyreva L, Jänigen B, Pisarski P (2017) Results of a randomized controlled trial analyzing telemedically supported case management in the first year after living donor kidney transplantation-a budget impact analysis from the healthcare perspective. Health Econ Rev 7(1):1CrossRef Kaier K, Hils S, Fetzer S, Hehn P, Schmid A, Hauschke D, Bogatyreva L, Jänigen B, Pisarski P (2017) Results of a randomized controlled trial analyzing telemedically supported case management in the first year after living donor kidney transplantation-a budget impact analysis from the healthcare perspective. Health Econ Rev 7(1):1CrossRef
19.
go back to reference Basch E, Deal AM, Dueck AC, Scher HI, Kris MG, Hudis C, Schrag D (2017) Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. Jama Basch E, Deal AM, Dueck AC, Scher HI, Kris MG, Hudis C, Schrag D (2017) Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. Jama
20.
go back to reference Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, Rogak L, Bennett AV, Dueck AC, Atkinson TM (2015) Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol :JCO630830 Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, Rogak L, Bennett AV, Dueck AC, Atkinson TM (2015) Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol :JCO630830
21.
go back to reference Haberlin C, O’Dwyer T, Mockler D, Moran J, O’Donnell DM, Broderick J (2018) The use of eHealth to promote physical activity in cancer survivors: a systematic review. Support Care Cancer:1–14 Haberlin C, O’Dwyer T, Mockler D, Moran J, O’Donnell DM, Broderick J (2018) The use of eHealth to promote physical activity in cancer survivors: a systematic review. Support Care Cancer:1–14
22.
go back to reference Bryant AL, Coffman E, Phillips B, Tan X, Bullard E, Hirschey R, Bradley J, Bennett AV, Stover AM, Song L (2020) Pilot randomized trial of an electronic symptom monitoring and reporting intervention for hospitalized adults undergoing hematopoietic stem cell transplantation. Support Care Cancer 28(3):1223–1231CrossRef Bryant AL, Coffman E, Phillips B, Tan X, Bullard E, Hirschey R, Bradley J, Bennett AV, Stover AM, Song L (2020) Pilot randomized trial of an electronic symptom monitoring and reporting intervention for hospitalized adults undergoing hematopoietic stem cell transplantation. Support Care Cancer 28(3):1223–1231CrossRef
23.
go back to reference Syrjala KL, Jean CY, Artherholt SB, Romano JM, Crouch M-L, Fiscalini AS, Hegel MT, Flowers ME, Martin PJ, Leisenring WM (2018) An online randomized controlled trial, with or without problem-solving treatment, for long-term cancer survivors after hematopoietic cell transplantation. J Cancer Survivorship 12(4):560–570CrossRef Syrjala KL, Jean CY, Artherholt SB, Romano JM, Crouch M-L, Fiscalini AS, Hegel MT, Flowers ME, Martin PJ, Leisenring WM (2018) An online randomized controlled trial, with or without problem-solving treatment, for long-term cancer survivors after hematopoietic cell transplantation. J Cancer Survivorship 12(4):560–570CrossRef
24.
go back to reference Glasgow RE, Phillips SM, Sanchez MA (2014) Implementation science approaches for integrating eHealth research into practice and policy. Int J Med Inform 83(7):e1–e11CrossRef Glasgow RE, Phillips SM, Sanchez MA (2014) Implementation science approaches for integrating eHealth research into practice and policy. Int J Med Inform 83(7):e1–e11CrossRef
25.
go back to reference Jeffs E, Vollam S, Young JD, Horsington L, Lynch B, Watkinson PJ (2016) Wearable monitors for patients following discharge from an intensive care unit: practical lessons learnt from an observational study. J Adv Nursing 72(8):1851–1862CrossRef Jeffs E, Vollam S, Young JD, Horsington L, Lynch B, Watkinson PJ (2016) Wearable monitors for patients following discharge from an intensive care unit: practical lessons learnt from an observational study. J Adv Nursing 72(8):1851–1862CrossRef
27.
go back to reference Simblett S, Greer B, Matcham F, Curtis H, Polhemus A, Ferrão J, Gamble P, Wykes T (2018) Barriers to and facilitators of engagement with remote measurement technology for managing health: systematic review and content analysis of findings. J Med Int Res20 (7) Simblett S, Greer B, Matcham F, Curtis H, Polhemus A, Ferrão J, Gamble P, Wykes T (2018) Barriers to and facilitators of engagement with remote measurement technology for managing health: systematic review and content analysis of findings. J Med Int Res20 (7)
28.
go back to reference Hamel LM, Thompson HS, Albrecht TL, Harper FW (2019) Designing and testing apps to support patients with cancer: looking to behavioral science to lead the way. JMIR Cancer 5 (1):e12317 Hamel LM, Thompson HS, Albrecht TL, Harper FW (2019) Designing and testing apps to support patients with cancer: looking to behavioral science to lead the way. JMIR Cancer 5 (1):e12317
31.
go back to reference Peters DH, Adam T, Alonge O, Agyepong IA, Tran N (2013) Implementation research: what it is and how to do it. BMJ 347:f6753 Peters DH, Adam T, Alonge O, Agyepong IA, Tran N (2013) Implementation research: what it is and how to do it. BMJ 347:f6753
32.
go back to reference Larusdottir M, Gulliksen J, Cajander Å (2017) A license to kill–Improving UCSD in Agile development. J Syst Software 123:214–222CrossRef Larusdottir M, Gulliksen J, Cajander Å (2017) A license to kill–Improving UCSD in Agile development. J Syst Software 123:214–222CrossRef
33.
go back to reference Schwaber K, Beedle M (2002) gilè software development with scrum. Schwaber K, Beedle M (2002) gilè software development with scrum.
34.
go back to reference Leppla L, Mielke J, Kunze M, Mauthner O, Teynor A, Valenta S, Vanhoof J, Dobbels F, Berben L, Zeiser R (2020) Clinicians and patients perspectives on follow-up care and eHealth support after allogeneic hematopoietic stem cell transplantation: a mixed-methods contextual analysis as part of the SMILe study. European J Oncol Nurs 45:101723. https://doi.org/10.1016/j.ejon.2020.101723CrossRef Leppla L, Mielke J, Kunze M, Mauthner O, Teynor A, Valenta S, Vanhoof J, Dobbels F, Berben L, Zeiser R (2020) Clinicians and patients perspectives on follow-up care and eHealth support after allogeneic hematopoietic stem cell transplantation: a mixed-methods contextual analysis as part of the SMILe study. European J Oncol Nurs 45:101723. https://​doi.​org/​10.​1016/​j.​ejon.​2020.​101723CrossRef
35.
go back to reference Michie S, Atkins L, West R, (2014) The behaviour change wheel: a guide to designing interventions. Silverback Publishing, Surrey. ISBN-13 Michie S, Atkins L, West R, (2014) The behaviour change wheel: a guide to designing interventions. Silverback Publishing, Surrey. ISBN-13
36.
go back to reference Leppla L, Hobelsberger S, Rockstein D, Werlitz V, Pschenitza S, Heidegger P, De Geest S, Valenta S, Teynor A (2021) Implementation science meets software development to create ehealth components for an integrated care model for allogeneic stem cell transplantation facilitated by eHealth: the SMILe study as an example. J Nurs Scholarsh 53(1):35–45. https://doi.org/10.1111/jnu.12621CrossRefPubMed Leppla L, Hobelsberger S, Rockstein D, Werlitz V, Pschenitza S, Heidegger P, De Geest S, Valenta S, Teynor A (2021) Implementation science meets software development to create ehealth components for an integrated care model for allogeneic stem cell transplantation facilitated by eHealth: the SMILe study as an example. J Nurs Scholarsh 53(1):35–45. https://​doi.​org/​10.​1111/​jnu.​12621CrossRefPubMed
38.
go back to reference Cohn M (2004) User stories applied: for agile software development. Addison-Wesley Professional Cohn M (2004) User stories applied: for agile software development. Addison-Wesley Professional
39.
go back to reference Kirsch M, Mitchell SA, Dobbels F, Stussi G, Basch E, Halter JP, De Geest S (2015) Linguistic and content validation of a German-language PRO-CTCAE-based patient-reported outcomes instrument to evaluate the late effect symptom experience after allogeneic hematopoietic stem cell transplantation. Eur J Oncol Nurs 19(1):66–74. https://doi.org/10.1016/j.ejon.2014.07.007CrossRefPubMed Kirsch M, Mitchell SA, Dobbels F, Stussi G, Basch E, Halter JP, De Geest S (2015) Linguistic and content validation of a German-language PRO-CTCAE-based patient-reported outcomes instrument to evaluate the late effect symptom experience after allogeneic hematopoietic stem cell transplantation. Eur J Oncol Nurs 19(1):66–74. https://​doi.​org/​10.​1016/​j.​ejon.​2014.​07.​007CrossRefPubMed
41.
go back to reference Howden EJ, La Gerche A, Arthur JF, McMullen JR, Jennings GL, Dunstan DW, Owen N, Avery S, Kingwell BA (2018) Standing up to the cardiometabolic consequences of hematological cancers. Blood Rev 32(5):349–360CrossRef Howden EJ, La Gerche A, Arthur JF, McMullen JR, Jennings GL, Dunstan DW, Owen N, Avery S, Kingwell BA (2018) Standing up to the cardiometabolic consequences of hematological cancers. Blood Rev 32(5):349–360CrossRef
42.
go back to reference Hashmi SK, Bredeson C, Duarte RF, Farnia S, Ferrey S, Fitzhugh C, Flowers ME, Gajewski J, Gastineau D, Greenwald M (2017) National institutes of health blood and marrow transplant late effects initiative: the Healthcare Delivery Working Group report. Biol Blood Marrow Transplant 23(5):717–725CrossRef Hashmi SK, Bredeson C, Duarte RF, Farnia S, Ferrey S, Fitzhugh C, Flowers ME, Gajewski J, Gastineau D, Greenwald M (2017) National institutes of health blood and marrow transplant late effects initiative: the Healthcare Delivery Working Group report. Biol Blood Marrow Transplant 23(5):717–725CrossRef
43.
go back to reference Giunti G, Giunta D, Guisado-Fernandez E, Bender J, Fernández-Luque L (2018) A biopsy of breast cancer mobile applications: state of the practice review. Int J Med Inform 110:1–9CrossRef Giunti G, Giunta D, Guisado-Fernandez E, Bender J, Fernández-Luque L (2018) A biopsy of breast cancer mobile applications: state of the practice review. Int J Med Inform 110:1–9CrossRef
44.
go back to reference Collado-Borrell R, Escudero-Vilaplana V, Ribed-Sánchez A, Ibáñez-García S, Herranz-Alonso A, Sanjurjo-Sáez M (2016) Smartphone applications for cancer patients; what we know about them. Farm Hosp 40(1):25–35PubMed Collado-Borrell R, Escudero-Vilaplana V, Ribed-Sánchez A, Ibáñez-García S, Herranz-Alonso A, Sanjurjo-Sáez M (2016) Smartphone applications for cancer patients; what we know about them. Farm Hosp 40(1):25–35PubMed
Metadata
Title
Development of an integrated model of care for allogeneic stem cell transplantation facilitated by eHealth—the SMILe study
Authors
Lynn Leppla
Anja Schmid
Sabine Valenta
Juliane Mielke
Sonja Beckmann
Janette Ribaut
Alexandra Teynor
Fabienne Dobbels
Nathalie Duerinckx
Robert Zeiser
Monika Engelhardt
Sabine Gerull
Sabina De Geest
the SMILe study team
Publication date
01-12-2021
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 12/2021
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-021-06328-0

Other articles of this Issue 12/2021

Supportive Care in Cancer 12/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine